Murdoch Childrens Research Institute
Clinical trials sponsored by Murdoch Childrens Research Institute, explained in plain language.
-
Booster battle: moderna vs. novavax for fourth COVID shot
⭐️ VACCINE ⭐️ OngoingThis study tests how well two different COVID-19 booster vaccines (Moderna and Novavax) work as a fourth dose in healthy adults who have already had three doses. About 496 participants in Australia will receive one of the two vaccines and be monitored for immune response and side…
Phase: PHASE3 • Sponsor: Murdoch Childrens Research Institute • Aim: ⭐️ VACCINE ⭐️
Last updated May 26, 2026 05:24 UTC
-
Breath of life: study tests best air pressure for tiny lungs
Disease control OngoingThis study looks at two methods of giving air pressure (PEEP) to help very premature babies open their lungs at birth. One method uses the same pressure throughout, while the other starts high and then lowers it. The goal is to see which approach reduces the risk of death or long…
Phase: NA • Sponsor: Murdoch Childrens Research Institute • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
Vitamin d for babies: a simple way to stop food allergies?
Prevention OngoingThis study tests whether giving vitamin D supplements to healthy, breastfed infants during their first year can lower their risk of developing food allergies. Over 2,700 babies in Australia are participating, and researchers will check for allergies at 12 months and again at 6 ye…
Phase: PHASE4 • Sponsor: Murdoch Childrens Research Institute • Aim: Prevention
Last updated May 26, 2026 05:23 UTC
-
Dads unite: new study tests peer support to beat baby blues
Symptom relief OngoingThis study tests a 6-week group program called Working Out Dads (WOD) to see if it helps reduce mental health struggles in fathers of children aged 0-4. About 293 dads with mild to moderate distress will either join the WOD peer-support group or receive usual care. The goal is to…
Phase: NA • Sponsor: Murdoch Childrens Research Institute • Aim: Symptom relief
Last updated May 18, 2026 12:08 UTC
-
New study aims to find safe scabies dose for toddlers
Knowledge-focused OngoingThis study looks at how ivermectin, a medicine for scabies, works in children under 5 years old. Researchers want to find the right dose that is both safe and effective for young kids, who are at higher risk for complications. About 120 children in Laos will take part, and the st…
Phase: PHASE2 • Sponsor: Murdoch Childrens Research Institute • Aim: Knowledge-focused
Last updated May 26, 2026 05:32 UTC
-
New infant ivermectin formula put to the test in adult volunteers
Knowledge-focused TerminatedThis study tests a new liquid version of the drug ivermectin, designed for infants, against the standard tablet. 52 healthy adults will try both forms to see if they work the same, taste okay, and have no new side effects. The goal is to make treating scabies easier for babies.
Phase: PHASE1 • Sponsor: Murdoch Childrens Research Institute • Aim: Knowledge-focused
Last updated May 20, 2026 11:54 UTC